Essex Investment Management’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,059
Closed -$59.4K 328
2023
Q4
$59.4K Sell
6,059
-4,301
-42% -$42.2K 0.01% 258
2023
Q3
$86.5K Sell
10,360
-99
-0.9% -$827 0.01% 301
2023
Q2
$139K Hold
10,459
0.02% 290
2023
Q1
$121K Buy
10,459
+4,601
+79% +$53.3K 0.02% 296
2022
Q4
$48K Hold
5,858
0.01% 318
2022
Q3
$34K Hold
5,858
0.01% 325
2022
Q2
$26K Sell
5,858
-4,549
-44% -$20.2K ﹤0.01% 346
2022
Q1
$95K Buy
10,407
+1,349
+15% +$12.3K 0.01% 319
2021
Q4
$185K Buy
9,058
+1,225
+16% +$25K 0.02% 313
2021
Q3
$200K Hold
7,833
0.02% 322
2021
Q2
$274K Buy
+7,833
New +$274K 0.03% 312
2017
Q3
Sell
-253,158
Closed -$901K 375
2017
Q2
$901K Buy
253,158
+102,640
+68% +$365K 0.13% 206
2017
Q1
$778K Buy
150,518
+75,837
+102% +$392K 0.12% 219
2016
Q4
$284K Buy
74,681
+28,857
+63% +$110K 0.05% 299
2016
Q3
$411K Sell
45,824
-1,075
-2% -$9.64K 0.07% 271
2016
Q2
$330K Sell
46,899
-517
-1% -$3.64K 0.05% 273
2016
Q1
$403K Sell
47,416
-32,120
-40% -$273K 0.07% 256
2015
Q4
$1.04M Sell
79,536
-73,939
-48% -$971K 0.16% 145
2015
Q3
$562K Buy
153,475
+6,423
+4% +$23.5K 0.09% 217
2015
Q2
$847K Sell
147,052
-3,092
-2% -$17.8K 0.13% 178
2015
Q1
$877K Sell
150,144
-1,109
-0.7% -$6.48K 0.12% 171
2014
Q4
$1.19M Sell
151,253
-23,949
-14% -$188K 0.17% 136
2014
Q3
$860K Sell
175,202
-11,289
-6% -$55.4K 0.13% 177
2014
Q2
$1.15M Buy
+186,491
New +$1.15M 0.17% 164
2014
Q1
Sell
-197,310
Closed -$1.03M 366
2013
Q4
$1.03M Buy
+197,310
New +$1.03M 0.15% 189